Otherwise, the number of EZH2-positive cells in tumors was significantly similarly lowered with 50 μM TMZ or VPA–NaDCA treatment, while 3 mM NaDCA did not affect EZH2 expression in the T98G tumor. The gene discussed is EZH2; the disease is neoplasm.